These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33098230)

  • 1. Genetic insight into COVID-19-related liver injury.
    Bianco C; Baselli G; Malvestiti F; Santoro L; Pelusi S; Manunta M; Grasselli G; Bandera A; Scudeller L; Prati D; Valenti L
    Liver Int; 2021 Jan; 41(1):227-229. PubMed ID: 33098230
    [No Abstract]   [Full Text] [Related]  

  • 2. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
    Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
    Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
    Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
    J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic analysis of acute liver injury during SARS-CoV-2 infection.
    Debes JD; Anugwom CM; Aby ES
    Dig Liver Dis; 2020 Sep; 52(9):953-955. PubMed ID: 32487506
    [No Abstract]   [Full Text] [Related]  

  • 5. Liver injury in COVID-19: What do we know now?
    Yang HY; Jin B; Mao YL
    Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):407-408. PubMed ID: 32753332
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
    Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features and Liver Injury in Patients with COVID-19 in the Japanese Population.
    Abe K; Yamamoto T; Matsumoto K; Kikuchi K; Miura R; Tachizawa N; Asaoka Y; Takezawa T; Matsunaga N; Obi S; Tanaka A
    Intern Med; 2020; 59(19):2353-2358. PubMed ID: 32999264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of coronavirus disease 2019 patients complicated with liver injury.
    Wen M; Lu J; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):555-559. PubMed ID: 32879106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe COVID-19 patients with liver injury: a seven-case series.
    Li X; Zhang ZC; Zhang PL
    Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7855-7860. PubMed ID: 32744713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACE2: from protection of liver disease to propagation of COVID-19.
    Warner FJ; Rajapaksha H; Shackel N; Herath CB
    Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case series and review of liver dysfunction in COVID-19 patients.
    Kudaravalli P; Saleem SA; Ibeche B; John S
    Eur J Gastroenterol Hepatol; 2020 Sep; 32(9):1244-1250. PubMed ID: 32568805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver infection and COVID-19: the electron microscopy proof and revision of the literature.
    Pirisi M; Rigamonti C; D'Alfonso S; Nebuloni M; Fanni D; Gerosa C; Orrù G; Venanzi Rullo E; Pavone P; Faa G; Saba L; Boldorini R
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):2146-2151. PubMed ID: 33660834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of acute liver injury and hypertransaminemia in patients with COVID-19: a protocol for a systematic review.
    Li G; Xu Y; Yang YT; Liu PF
    BMJ Open; 2020 Jul; 10(7):e040517. PubMed ID: 32641369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver diseases in COVID-19: Etiology, treatment and prognosis.
    Wu J; Song S; Cao HC; Li LJ
    World J Gastroenterol; 2020 May; 26(19):2286-2293. PubMed ID: 32476793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 and the liver: What do we know after six months of the pandemic?
    Fierro NA
    Ann Hepatol; 2020; 19(6):590-591. PubMed ID: 32956871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection in patients with a normal or abnormal liver.
    Cabibbo G; Rizzo GEM; Stornello C; Craxì A
    J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and risk factors of COVID-19-associated liver injury and function: A retrospective analysis of 830 cases.
    Chen F; Chen W; Chen J; Xu D; Xie W; Wang X; Xie Y
    Ann Hepatol; 2021; 21():100267. PubMed ID: 33053426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 and Digestive System in Children: A Retrospective Study.
    Esmaeili Dooki M; Mehrabani S; Sorkhi H; Nikpour M; Tabatabaie M; Mohammadi M; Kiani M
    Arch Iran Med; 2020 Nov; 23(11):782-786. PubMed ID: 33220697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver Biopsy Shines a Light on COVID-19-Related Liver Injury.
    Kleiner DE
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):881-882. PubMed ID: 33144089
    [No Abstract]   [Full Text] [Related]  

  • 20. The clinical manifestations and management of COVID-19-related liver injury.
    Su TH; Kao JH
    J Formos Med Assoc; 2020 Jun; 119(6):1016-1018. PubMed ID: 32345544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.